Novartis-owned AveXis bringing $55M gene therapy factory, 200 jobs to Durham – WRAL Tech Wire
WRAL Tech Wire |
Novartis-owned AveXis bringing $55M gene therapy factory, 200 jobs to Durham
WRAL Tech Wire AveXis intends to use its new Durham facility to manufacture its first product candidate, AVXS-101, its proprietary gene therapy to treat three types of spinal muscular atrophy, or SMA. SMA Type 1 is the leading genetic cause of infant mortality.As … |
